{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:53:51Z","timestamp":1791179631689,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"\n Background<\/jats:title>\n Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease characterized by multi-organ fibrosis and vasculopathy that frequently involves the esophagus. This study assessed esophageal motility disorders in patients with SSc using High-resolution manometry (HRM) and classified these disorders according to the Chicago Classification version 4.0, aims to investigate the associations between esophageal dysfunction and clinical phenotypes in Chinese SSc patients, while exploring potential modifications to enhance the applicability of the Chicago v4.0 protocol in SSc patients.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We retrospectively identified SSc patients fulfilling 2013 ACR criteria who underwent HRM classified by Chicago v4.0 at our center (2021\u20132023). Demographics, organ involvement, pulmonary-function tests, echocardiography and reflux symptom scores (RDQ\/GERDQ) were extracted from the hospital information system; age and sex matched non-SSc HRM subjects served as controls. Associations between Chicago categories and clinical variables were examined by multinomial logistic regression.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n In our study, esophageal motility disorders were present in 76.7% of patients with systemic sclerosis, predominantly characterized by ineffective esophageal motility (IEM) (35%) and absent contractility (AC) (36.67%). The occurrence rate of AC rose with age. Symptoms of gastroesophageal reflux were more common in the AC group [Odds Ratio: 3.23 (1.02-10.22) vs 1.43(0.52-3.95), P&lt;0.05, E value=2.99]. Diffusion capacity for carbon monoxide (DLCO) was significantly reduced in both IEM and AC (-2.03 vs -2.70, P value&lt;0.05), with a more pronounced decrease in AC. Total lung capacity (TLC) and forced expiratory volume in one second (FEV1) exhibited stronger associations with AC (-1.04 and -0.8 respectively, p value&lt;0.05). Upright HRM revealed more marked decreases in EGJ pressure and distal contractile integral (DCI) relative to the supine position in SSc patients, indicating that esophageal abnormalities may be more readily apparent during upright examination.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Esophageal motility disorders in SSc were common and significantly associated with older age, gastroesophageal reflux symptoms, and reduced lung function. Future studies are needed to clarify whether early esophageal motility disorders are associated with disease progression and prognosis in patients.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1962332","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:04Z","timestamp":1791178324000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The application of Chicago classification 4.0 in esophageal motility disorders of scleroderma: a case-control study in China"],"prefix":"10.3389","volume":"17","author":[{"given":"Yinghui","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Xie","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Third Affiliated Hospital of Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Third Affiliated Hospital of Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/bf00371817","article-title":"Epidemiological study of patients with systemic sclerosis in Tokyo","volume":"283","author":"Tamaki","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.553736","article-title":"Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan","volume":"40","author":"Kuo","year":"2011","journal-title":"Scandinavian J Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15838","article-title":"Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population-based study","volume":"178","author":"Kang","year":"2018","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheumatism"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111106","article-title":"Epidemiology of systemic sclerosis in a large US managed care population","volume":"39","author":"Furst","year":"2012","journal-title":"J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20656","article-title":"Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada","volume":"64","author":"Barnabe","year":"2012","journal-title":"Arthritis Care Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203618","article-title":"Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria","volume":"73","author":"Andr\u00e9asson","year":"2014","journal-title":"Ann Rheumatic Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes076","article-title":"Prevalence of systemic sclerosis in south-east Norway","volume":"51","author":"Hoffmann-Vold","year":"2012","journal-title":"Rheumatol (Oxford England)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5604\/12321966.1233570","article-title":"Incidence and prevalence of Systemic Sclerosis (SSc) in Poland - differences between rural and urban regions","volume":"24","author":"Kanecki","year":"2017","journal-title":"Ann Agric Environ Med AAEM"},{"key":"B10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00296-015-3330-1","article-title":"Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012","volume":"36","author":"Piga","year":"2016","journal-title":"Rheumatol Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000008980","article-title":"Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheumatic Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/23971983221074749","article-title":"Systemic sclerosis in Asians: Are there racial differences","volume":"7","author":"Ng","year":"2022","journal-title":"J Scleroderma Related Disord"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01962-y","article-title":"Clinical characteristics and treatment patterns of systemic sclerosis patients in China: a single-center retrospective study","volume":"26","author":"Tian","year":"2026","journal-title":"Clin Exp Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180042","article-title":"Ethnic variations in systemic sclerosis disease manifestations, internal organ involvement, and mortality","volume":"46","author":"Al-Sheikh","year":"2019","journal-title":"J Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5056\/jnm19148","article-title":"Esophageal involvement and determinants of perception of esophageal symptoms among South Koreans with systemic sclerosis","volume":"26","author":"Lee","year":"2020","journal-title":"J Neurogastroenterol Motil"},{"key":"B17","article-title":"High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity","author":"Raja","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01578-6","article-title":"Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis","volume":"54","author":"Kuribayashi","year":"2019","journal-title":"J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25080","article-title":"Associations between patterns of esophageal dysmotility and extra-intestinal features in patients with systemic sclerosis","volume":"75","author":"Tucker","year":"2023","journal-title":"Arthritis Care Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12813","article-title":"The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters","volume":"28","author":"Kimmel","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doag031","article-title":"Esophageal motor dysfunction in systemic sclerosis: clinical predictors and a risk stratification model","volume":"39","author":"Piskorz","year":"2026","journal-title":"Dis Esophagus"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf433","article-title":"Oesophageal dysmotility patterns are associated with distinct clinical phenotypes and prognosis in patients with systemic sclerosis","volume":"64","author":"Alcala-Gonzalez","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2026.107374","article-title":"Objective gastrointestinal involvement in patients with systemic sclerosis: Prevalence and clinico-immunological phenotypes in the REMSCLE registry","volume":"166","author":"Ezquerra-Dur\u00e1n","year":"2026","journal-title":"Med Clin (Barc)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14058","article-title":"Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(\u00a9)","volume":"33","author":"Yadlapati","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheumatic Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4026-1","article-title":"Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value","volume":"37","author":"Vettori","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)45:4<346::aid-art347>3.0.co;2-l","article-title":"Esophageal involvement and pulmonary manifestations in systemic sclerosis","volume":"45","author":"Marie","year":"2001","journal-title":"Arthritis Rheumatism"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05399-y","article-title":"Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study","volume":"44","author":"Marten Canavesio","year":"2024","journal-title":"Rheumatol Int"},{"key":"B29","article-title":"Esophageal motor abnormalities on high-resolution manometry in patients with scleroderma","volume":"99","author":"Labidi","year":"2021","journal-title":"La Tunisie Medicale"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14284","article-title":"Heterogeneity of primary and secondary peristalsis in systemic sclerosis: A new model of \"scleroderma esophagus","volume":"34","author":"Carlson","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/2050640614560453","article-title":"Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study","volume":"3","author":"Karamanolis","year":"2015","journal-title":"United Eur Gastroenterol J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13075-016-1094-y","article-title":"The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial","volume":"18","author":"Karamanolis","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2026.03.022","article-title":"Gastrointestinal disorders in scleroderma","volume":"171","author":"Quigley","year":"2026","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.64898\/2026.04.13.26350585","article-title":"PPI-refractory GERD in systemic sclerosis is driven by distinct esophageal and gastric motility abnormalities","volume":"2026","author":"Alcala-Gonzalez","year":"2026","journal-title":"Rheumatol (Oxford)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1962332\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:05Z","timestamp":1791178325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1962332\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2026.1962332"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1962332","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1962332"}}